Title
AN ACT relating to coverage for diabetes treatment.
Summary of Original Version
Amend KRS 304.17A-148 to require that cost sharing for noninsulin drugs and certain equipment and supplies necessary for the treatment of diabetes not exceed certain cost-sharing thresholds; prohibit insurers from conducting or imposing utilization review for diabetes treatment prescribed by a health care provider; EFFECTIVE January 1, 2023.
Sponsors
Documents
Introduced .pdf
(23.77 KB)
Session
Index Headings of Original Version
Diabetes treatment, insurance requirements, health plan
Diabetes treatment, insurance requirements
Diabetes drugs, equipment, and supplies, cost-sharing limitation
Diabetes treatment, insurance requirements, January 1, 2023
Diabetes treatment, cost-sharing limitation
Diabetes treatment, utilization review prohibition
Diabetes treatment, insurance requirements, health plan
Actions
11/23/21
- Prefiled by the sponsor(s).
01/04/22
- introduced in House